Pharvaris N.V. (PHVS) stock
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$33.83−0.35 (-1.02%)
Close on Nov 12, 2026Market cap $2.21BP/E –Yield –
Pharvaris cash
Cash and short-term investments held at the end of each period.
Pharvaris's cash was €318.28M at Jun 30, 2026. For fiscal 2025 it was €291.68M, up 3.9% from the year before. The highest annual figure on record is €391.23M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €291.68M | +3.9% |
| FY2024 | Dec 31, 2024 | €280.73M | -28.2% |
| FY2023 | Dec 31, 2023 | €391.23M | +141.7% |
| FY2022 | Dec 31, 2022 | €161.84M | -22.7% |
| FY2021 | Dec 31, 2021 | €209.35M | +112.3% |
| FY2020 | Dec 31, 2020 | €98.63M | +385.2% |
| FY2019 | Dec 31, 2019 | €20.33M | +277.4% |
| FY2018 | Dec 31, 2018 | €5.39M | +12.3% |
| FY2017 | Dec 31, 2017 | €4.80M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €318.28M | -7.4% |
| Q4 FY2025 | Dec 31, 2025 | €291.68M | -25.4% |
| Q2 FY2025 | Jun 30, 2025 | €199.57M | +11.4% |
| Q4 FY2024 | Dec 31, 2024 | €280.73M | +73.5% |
| Q2 FY2024 | Jun 30, 2024 | €343.57M | +70.6% |
| Q4 FY2023 | Dec 31, 2023 | €391.23M | +86.9% |
| Q2 FY2023 | Jun 30, 2023 | €179.19M | -20.1% |
| Q4 FY2022 | Dec 31, 2022 | €161.84M | +64.1% |
| Q2 FY2022 | Jun 30, 2022 | €201.38M | +890.7% |
| Q4 FY2021 | Dec 31, 2021 | €209.35M | +3787.5% |
| Q2 FY2021 | Jun 30, 2021 | €224.32M | +4578.0% |
| Q4 FY2020 | Dec 31, 2020 | €98.63M | – |
| Q4 FY2019 | Dec 31, 2019 | €20.33M | – |
| Q4 FY2018 | Dec 31, 2018 | €5.39M | – |
| Q4 FY2017 | Dec 31, 2017 | €4.80M | – |
See a number that looks wrong?